(Reuters) – Moderna Inc said on Friday that it plans to build an mRNA vaccine manufacturing facility in Quebec province to support a long-term partnership with the Government of Canada.
The facility can produce up to 100 million mRNA respiratory vaccine doses annually, the COVID-19 vaccine maker said in a statement.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Arun Koyyur)
